These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6683530)

  • 1. Antimycotic efficacy of bifonazole in vitro and in vivo.
    Plempel M; Regel E; Büchel KH
    Arzneimittelforschung; 1983; 33(4):517-24. PubMed ID: 6683530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo studies with flutrimazole, a new imidazole derivative with antifungal activity.
    García Rafanell J; Dronda MA; Merlos M; Forn J; Torres JM; Zapatero MI; Basi N
    Arzneimittelforschung; 1992 Jun; 42(6):836-40. PubMed ID: 1418042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro studies of a new imidazole antimycotic, bifonazole, in comparison with clotrimazole and miconazole.
    Yamaguchi H; Hiratani T; Plempel M
    Arzneimittelforschung; 1983; 33(4):546-51. PubMed ID: 6683531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of bifonazole (BAY H 4502) with clotrimazole in vitro.
    Shadomy S; Dixon DM; May R
    Sabouraudia; 1982 Dec; 20(4):313-23. PubMed ID: 7157107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo activity of bifonazole in guinea pigs: its characteristic features and comparison with clotrimazole.
    Yamaguchi H; Uchida K
    Dermatologica; 1984; 169 Suppl 1():33-45. PubMed ID: 6526090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bifonazole. A review of its antimicrobial activity and therapeutic use in superficial mycoses.
    Lackner TE; Clissold SP
    Drugs; 1989 Aug; 38(2):204-25. PubMed ID: 2670516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An evaluation of the antifungal effect of bifonazole on Torulopsis glabrata and Candida albicans under various in vitro test conditions.
    Barug D; Bastiaanse HB
    Arzneimittelforschung; 1983; 33(4):524-8. PubMed ID: 6409128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preclinical and clinical studies on the efficacy of bifonazole in patients with tinea pedis at 10 years after approval. Part 1. Susceptibility to bifonazole of clinical isolates of dermatophytes].
    Yamaguchi H; Uchida K; Watanabe S; Takahashi H; Nakamura Y; Nakamura E; Nishiyama Y; Teduka M; Tomizawa T; Shimozuma M; Osada A; Kawano S; Nakauchi Y; Wakukawa M; Goto A; Ueda Y; Matsukawa A; Kubo M; Minami H; Arikawa J; Soma Y; Chi HI; Tamaki K
    Jpn J Antibiot; 1996 Dec; 49(12):1085-94. PubMed ID: 9032595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bifonazole and clotrimazole. Their mode of action and the possible reason for the fungicidal behaviour of bifonazole.
    Berg D; Regel E; Harenberg HE; Plempel M
    Arzneimittelforschung; 1984; 34(2):139-46. PubMed ID: 6372801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxiconazole, a new imidazole derivative. Evaluation of antifungal activity in vitro and in vivo.
    Polak A
    Arzneimittelforschung; 1982; 32(1):17-24. PubMed ID: 7037014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental in vitro and in vivo comparison of modern antimycotics.
    Haller I; Plempel M
    Curr Med Res Opin; 1977-1978; 5(4):315-27. PubMed ID: 630908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bifonazole, a biochemist's view.
    Berg D; Plempel M
    Dermatologica; 1984; 169 Suppl 1():3-9. PubMed ID: 6396116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxiconazole nitrate: pharmacology, efficacy, and safety of a new imidazole antifungal agent.
    Jegasothy BV; Pakes GE
    Clin Ther; 1991; 13(1):126-41. PubMed ID: 2029718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Six novel antimycotics.
    Rubin AI; Bagheri B; Scher RK
    Am J Clin Dermatol; 2002; 3(2):71-81. PubMed ID: 11893219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapeutic evaluation of clotrimazole (Bay b 5097, 1 (o-chloro- - -diphenylbenzyl) imidazole).
    Waitz JA; Moss EL; Weinstein MJ
    Appl Microbiol; 1971 Nov; 22(5):891-8. PubMed ID: 4943591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro antifungal activity of KP-103, a novel triazole derivative, and its therapeutic efficacy against experimental plantar tinea pedis and cutaneous candidiasis in guinea pigs.
    Tatsumi Y; Yokoo M; Arika T; Yamaguchi H
    Antimicrob Agents Chemother; 2001 May; 45(5):1493-9. PubMed ID: 11302816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic efficacy of lanoconazole, a new imidazole antimycotic agent, for experimental cutaneous candidiasis in guinea pigs.
    Niwano Y; Seo A; Kanai K; Hamaguchi H; Uchida K; Yamaguchi H
    Antimicrob Agents Chemother; 1994 Sep; 38(9):2204-6. PubMed ID: 7811048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microscopic studies of Candida albicans and Torulopsis glabrata after in vitro treatment with bifonazole. Light and scanning electron microscopy.
    Barug D; Samson RA; Kerkenaar A
    Arzneimittelforschung; 1983; 33(4):528-37. PubMed ID: 6347209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vitro antifungal activity of omoconazole nitrate, a new imidazole antimycotic].
    Itoyama T; Aoki Y; Hiratani T; Uchida K; Yamaguchi H
    Jpn J Antibiot; 1993 Sep; 46(9):773-80. PubMed ID: 8254897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of fungicidal action in vitro and in a skin model considering the influence of penetration kinetics of various standard antimycotics.
    Hänel H; Raether W; Dittmar W
    Ann N Y Acad Sci; 1988; 544():329-37. PubMed ID: 3214073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.